FDA's controversial vaccine chief will exit agency next month [CNN]
uniQure N.V. - Ordinary Shares (QURE)
Last uniqure n.v. - ordinary shares earnings: 4/29 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
uniqure.com/investors-newsroom/overview.php
Company Research
Source: CNN
Dr. Vinay Prasad, who joined the FDA in May, oversaw a series of vaccine decisions that attracted controversy, including a refusal last month to review a new flu vaccine using messenger RNA technology, made by Moderna. The agency later accepted the application with adjustments. FDA Commissioner Dr. Marty Makary has not made a decision on a replacement to lead the agency's Center for Biologics Evaluation and Research, he said in a social media post Friday. Prasad's departure was first reported by the Wall Street Journal. Prasad had previously left the agency in July, less than three months into the job, before rejoining weeks later. That departure came amid increasing pressure from White House allies including Laura Loomer, who accused the hematologist-oncologist of being politically aligned with liberals and expressing “disdain” for President Donald Trump. More recently, CBER has been embroiled in controversy over requests for more trial data from a company, UniQure, developi
Show less
Read more
Impact Snapshot
Event Time:
QURE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QURE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QURE alerts
High impacting uniQure N.V. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
QURE
News
- uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QUREPR Newswire
- FDA Vaccine Chief Vinay Prasad Set to Leave Post Next Month [Yahoo! Finance Canada]Yahoo! Finance Canada
- FDA Vaccine Chief Vinay Prasad Set to Leave Post Next Month [Yahoo! Finance]Yahoo! Finance
- FDA's controversial vaccine chief will exit agency next month [CNN]CNN
- UPCOMING DEADLINE: uniQure N.V. (QURE) Securities Fraud Class Action – April 13, 2026 Lead Plaintiff Deadline - Faruqi & Faruqi LLPGlobeNewswire
QURE
Earnings
- 11/10/25 - Miss
QURE
Sec Filings
- 3/6/26 - Form 4
- 3/6/26 - Form 4
- 3/6/26 - Form 4
- QURE's page on the SEC website